“Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers”, J Infec Dis, vol. 183, pp. 1343-52, 2001.
“A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers”, J Infec Dis, vol. 180, pp. 290-8, 1999.
, “HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine”, AIDS Res HumRetroviruses, vol. 15, pp. 115-32, 1999.
, “Immunization with envelope MN rap 120 vaccine in human immunodeficiency virus infected pregnant women”, J Infec Dis, vol. 180, pp. 1080-8, 1999.
, “Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines”, J Infec Dis, vol. 177, pp. 310-319, 1998.
,